nocodazole has been researched along with Cancer of Prostate in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eupatorin likely has additional targets since eupatorin treatment of pre-mitotic cells causes spindle anomalies triggering a transient M phase delay followed by impaired cytokinesis and polyploidy." | 5.38 | The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis. ( Jaakkola, K; Kallio, L; Kallio, MJ; Kukkonen-Macchi, A; Mäki-Jouppila, J; Pouwels, J; Salmela, AL; Toivonen, P; Waris, S, 2012) |
| "The analysis of prostate cancer cells synchronized with nocodazole demonstrated that the expression of Tau protein phosphorylated at residue Thr231 is restricted to G2/M cell cycle phase." | 1.91 | Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells. ( Angelucci, A; Clementi, L; Compagnoni, C; Mattei, V; Sabetta, S; Tessitore, A; Zelli, V, 2023) |
| "Eupatorin likely has additional targets since eupatorin treatment of pre-mitotic cells causes spindle anomalies triggering a transient M phase delay followed by impaired cytokinesis and polyploidy." | 1.38 | The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis. ( Jaakkola, K; Kallio, L; Kallio, MJ; Kukkonen-Macchi, A; Mäki-Jouppila, J; Pouwels, J; Salmela, AL; Toivonen, P; Waris, S, 2012) |
| "Here we demonstrated that Pim-1-induced polyploidy develops in a passage-dependent manner in culture consistent with a stochastic mode of progression." | 1.33 | Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1. ( Abdulkadir, SA; Kim, J; Roh, M; Song, C, 2005) |
| "Immunohistochemistry of human prostate cancer specimens demonstrated higher levels of EGR-1 in malignant cells located predominantly in the cytoplasm, whereas benign cells contained lower levels of EGR-1 located predominantly in the nucleus." | 1.32 | The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. ( Cheville, JC; Lingle, WL; Mitchell, RF; Mora, GR; Olivier, KR; Tindall, DJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mandalapu, D | 1 |
| Saini, KS | 1 |
| Gupta, S | 1 |
| Sharma, V | 1 |
| Yaseen Malik, M | 1 |
| Chaturvedi, S | 1 |
| Bala, V | 1 |
| Thakur, S | 1 |
| Maikhuri, JP | 1 |
| Wahajuddin, M | 1 |
| Konwar, R | 1 |
| Gupta, G | 1 |
| Sharma, VL | 1 |
| Clementi, L | 1 |
| Sabetta, S | 1 |
| Zelli, V | 1 |
| Compagnoni, C | 1 |
| Tessitore, A | 1 |
| Mattei, V | 1 |
| Angelucci, A | 1 |
| Gheghiani, L | 1 |
| Shang, S | 1 |
| Fu, Z | 1 |
| Moretti, L | 1 |
| Niermann, K | 1 |
| Schleicher, S | 1 |
| Giacalone, NJ | 1 |
| Varki, V | 1 |
| Kim, KW | 1 |
| Kopsombut, P | 1 |
| Jung, DK | 1 |
| Lu, B | 1 |
| Salmela, AL | 1 |
| Pouwels, J | 1 |
| Kukkonen-Macchi, A | 1 |
| Waris, S | 1 |
| Toivonen, P | 1 |
| Jaakkola, K | 1 |
| Mäki-Jouppila, J | 1 |
| Kallio, L | 1 |
| Kallio, MJ | 1 |
| Mora, GR | 1 |
| Olivier, KR | 1 |
| Cheville, JC | 1 |
| Mitchell, RF | 1 |
| Lingle, WL | 1 |
| Tindall, DJ | 1 |
| Reimer, TA | 1 |
| Anagnostopoulos, I | 1 |
| Erdmann, B | 1 |
| Lehmann, I | 1 |
| Stein, H | 1 |
| Daniel, P | 1 |
| Dörken, B | 1 |
| Rehm, A | 1 |
| Roh, M | 1 |
| Song, C | 1 |
| Kim, J | 1 |
| Abdulkadir, SA | 1 |
| Srivastava, RK | 1 |
| Srivastava, AR | 1 |
| Korsmeyer, SJ | 1 |
| Nesterova, M | 1 |
| Cho-Chung, YS | 1 |
| Longo, DL | 1 |
| Sprenger, CC | 1 |
| Vail, ME | 1 |
| Evans, K | 1 |
| Simurdak, J | 1 |
| Plymate, SR | 1 |
10 other studies available for nocodazole and Cancer of Prostate
| Article | Year |
|---|---|
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle Checkpoin | 2016 |
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells.
Topics: Cell Cycle; Humans; Male; Mitosis; Nocodazole; Phosphorylation; Prostatic Neoplasms; tau Proteins | 2023 |
Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; Drug Synergism; Forkh | 2020 |
MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
Topics: Androgens; Animals; Apoptosis; Aurora Kinase A; Aurora Kinases; Benzazepines; Caspase 3; Cell Cycle; | 2011 |
The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis.
Topics: Antimitotic Agents; Apoptosis; Aurora Kinase B; Aurora Kinases; Cell Culture Techniques; Cell Prolif | 2012 |
The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Nucleu | 2004 |
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate | 2005 |
Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1.
Topics: Animals; Cattle; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Line, Tumor; Chromosomes, Huma | 2005 |
Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Caspases; | 1998 |
Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Carrier Proteins; Cell Cycle Proteins; Cell Division; | 2002 |